Please login to view this media
- Talk
- 13/09/2021
- UK
Longer-term Risks and Benefits of Recurrent Intra-articular Corticosteroid Injections (IACIs) for Osteoarthritis: A Systematic Review and Meta-analysis
Description
The presentation discusses a systematic review and meta-analysis conducted by Richard Donovan on the longer-term risks and benefits of recurrent intra-articular corticosteroid injections for arthritis, particularly focusing on osteoarthritis treatments. The analysis evaluated existing literature to compare outcomes of patients receiving repeated steroid injections versus other injectables, placebos, or no treatment, with a primary focus on pain and function over time frames extending beyond three months.
Initial findings indicated a fragmented data landscape with only 10 relevant studies identified after an initial review of 594 papers. These studies included almost 900 patients with a predominant focus on knee and thumb osteoarthritis. Results showed that while all injectables provided some symptom relief, non-steroidal alternatives tended to yield better long-term pain and functional outcomes, with saline injections outperforming steroids in some cases. The analysis also highlighted significant limitations within the included studies, such as small sample sizes, lack of definition for clinically significant differences, and variables in steroid application methods.
During a discussion with colleagues, further questions addressed the quality of the studies, the extent of disease progression monitoring, and the potential impact of ongoing studies, such as the RUbICOn study in Bristol, which aims to explore the systemic effects of repeated corticosteroid injections. The overall takeaways emphasize the necessity for future research into the risks associated with recurrent corticosteroid injections and the benefits of alternative therapies in managing arthritis.